Lifecore Biomedical Q2 rev up 13% YoY to $11.6mln.

• LifeCore Biomedical reports Q2 revenue of $11.6mln, up 13% YoY. • Q2 revenue increased by $365,000 due to favorable foreign currency translation. • Six-month revenue of $21.5mln, up 12% YoY. • Six-month loss reduced to $246,000, down from $2.2mln in the prior year.